相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HspB1 Dynamic Phospho-Oligomeric Structure Dependent Interactome as Cancer Therapeutic Target
A-P. Arrigo et al.
CURRENT MOLECULAR MEDICINE (2012)
Small heat shock proteins in cancer therapy and prognosis
Amina Zoubeidi et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Small heat shock proteins HSP27 (HspB1), αB-crystallin (HspB5) and HSP22 (HspB8) as regulators of cell death
Julie Acunzo et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
The small heat shock proteins family: The long forgotten chaperones
C. Garrido et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Small heat shock proteins and the cytoskeleton: An essential interplay for cell integrity?
G. Wettstein et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Cells Lacking the Fumarase Tumor Suppressor Are Protected from Apoptosis through a Hypoxia-Inducible Factor-Independent, AMPK-Dependent Mechanism
Chiara Bardella et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Antitumor Action of the MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) in Gastric Cancer Positive for MET Amplification
Wataru Okamoto et al.
MOLECULAR CANCER THERAPEUTICS (2012)
LEDGF gene silencing impairs the tumorigenicity of prostate cancer DU145 cells by abating the expression of Hsp27 and activation of the Akt/ERK signaling pathway
B. Bhargavan et al.
CELL DEATH & DISEASE (2012)
METMutations in Cancers of Unknown Primary Origin (CUPs)
Giulia M. Stella et al.
HUMAN MUTATION (2011)
Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab
E. F. Dunn et al.
ONCOGENE (2011)
Inhibition of heat shock protein 27 (HspB1) tumorigenic functions by peptide aptamers
B. Gibert et al.
ONCOGENE (2011)
OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer
V. Baylot et al.
CELL DEATH & DISEASE (2011)
Gastric cancer cell line Hs746T harbors a splice site mutation of c-Met causing juxtamembrane domain deletion
Yoshinari Asaoka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Fumarase tumor suppressor gene and MET oncogene cooperate in upholding transformation and tumorigenesis
Barbara Costa et al.
FASEB JOURNAL (2010)
Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application
Aimee L. Jackson et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
MET signalling: principles and functions in development, organ regeneration and cancer
Livio Trusolino et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Heat shock factors: integrators of cell stress, development and lifespan
Malin Akerfelt et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E
C. Andrieu et al.
ONCOGENE (2010)
Heat Shock Proteins: Cell Protection through Protein Triage
David Lanneau et al.
THESCIENTIFICWORLDJOURNAL (2010)
Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology
Sergiy Kostenko et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Only a Subset of Met-Activated Pathways Are Required to Sustain Oncogene Addiction
Andrea Bertotti et al.
SCIENCE SIGNALING (2009)
Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability
Se Hun Kang et al.
BMC CANCER (2008)
Drug development of MET inhibitors: targeting oncogene addiction and expedience
Paolo M. Comoglio et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Proteomic analysis of hypoxia-induced tube breakdown of an in vitro capillary model composed of HUVECs:: Potential role of p38-regulated reduction of HSP27
Ryoji Eguchi et al.
PROTEOMICS (2008)
Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity
Arnina Zoubeidi et al.
CANCER RESEARCH (2007)
Responses of cancer cells with wild-type or tyrosine kinase domain-mutated epidermal growth factor receptor (EGFR) to EGFR-targeted therapy are linked to downregulation of hypoxia-inducible factor-1α
Yang Lu et al.
MOLECULAR CANCER (2007)
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
Jeffrey A. Engelman et al.
SCIENCE (2007)
p38 MAPK turns hepatocyte growth factor to a death signal that commits ovarian cancer cells to chemotherapy-induced apoptosis
Nadia Coltella et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Hsp27 upregulation by HIF-1 signaling offers protection against retinal ischemia in rats
NA Whitlock et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
LEDGF, a survival factor, activates stress-related genes
T Shinohara et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2002)
A novel germ line juxtamembrane Met mutation in human gastric cancer
JH Lee et al.
ONCOGENE (2000)
Differential regulation of HSP27 oligomerization in tumor cells grown in vitro and in vivo
JM Bruey et al.
ONCOGENE (2000)
Hsp27 functions as a negative regulator of cytochrome c-dependent activation of procaspase-3
P Pandey et al.
ONCOGENE (2000)
Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas
MF Di Renzo et al.
ONCOGENE (2000)
分享论文
